We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Image α-Synuclein Aggregration
Editor's Pics

Image α-Synuclein Aggregration

Image α-Synuclein Aggregration
Editor's Pics

Image α-Synuclein Aggregration

α-synuclein aggregation is a hallmark characteristic of Parkinson’s disease. Recent studies have revealed that microglia, activated by α-synuclein, can produce cytokines that in turn cause neurons to express MHC I. If these neurons express a specific combination of MHC alleles and peptide, they are targeted for destruction by CD8+ T cells. BioLegend provides reagents to specifically identify antigen-specific T cells with our MHC tetramer technology: Flex-T™. In addition, we offer several phospho- and conformation-specific antibodies for the detection of α-synuclein.

Learn more about these product lines at:

http://www.biolegend.com/flex-t

http://www.biolegend.com/asynuclein_aggregate_Abs


Image α-Synuclein Aggregration



Advertisement